The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Park Place Capital Corp

Park Place Capital Corp trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 11.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,023 shares of the medical device company’s stock after selling 137 shares during the period. Park Place Capital Corp’s holdings in Cooper Companies were worth $94,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in the business. Ashton Thomas Securities LLC purchased a new stake in Cooper Companies during the third quarter worth approximately $25,000. Covestor Ltd raised its holdings in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after purchasing an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. lifted its position in shares of Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after buying an additional 275 shares during the last quarter. West Financial Advisors LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at $49,000. Finally, Friedenthal Financial acquired a new position in shares of Cooper Companies in the 3rd quarter valued at $50,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

NASDAQ:COO opened at $95.18 on Thursday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $19.00 billion, a price-to-earnings ratio of 48.81, a price-to-earnings-growth ratio of 2.36 and a beta of 0.99. The firm’s fifty day moving average price is $96.07 and its 200 day moving average price is $99.17. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.87 earnings per share. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

A number of brokerages recently weighed in on COO. Citigroup reduced their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Morgan Stanley decreased their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.